TY - JOUR T1 - Sequencing Data of North American SARS-CoV-2 Isolates Shows Widespread Complex Variants JF - medRxiv DO - 10.1101/2021.01.27.21250648 SP - 2021.01.27.21250648 AU - Colby T. Ford AU - Rachel Scott AU - Denis Jacob Machado AU - Daniel Janies Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/01/29/2021.01.27.21250648.abstract N2 - Several new variants of the SARS-CoV-2 have been isolated in the United States, Mexico, and Canada. Many of the variants contain single variants of functional significance (e.g. S: N501Y increases transmissibility). To study the occurrence and co-circulation of these variants, we have developed an easy-to-use dashboard at janieslab.github.io/sars-cov-2.We created a multiple sequence alignment workflow and processing script to generate a variant dataset, which populates this dashboard. We then use the features of the dashboard, such as visualization of the single and complex nucleotide variants geospatially and in a color-coded matrix format. Users also interact with the dashboard to filter the underlying data to regions of interest and or variants of interest. The user can export reports based on the desired filters, which we intend to be used for regionally specific pandemic response. We find in Genbank, an isolate from Massachusetts containing [(S: Q677H), (ORF3a: Q57H), (M: A85S), (N: D377Y)] collected on September 11, 2020.Moreover, we find that many viral isolates bear a marker of increased transmissibility (S: N501Y) in linkage with at least one variant of concern isolated from Ohio also range across the Untied States and stretch from British Columbia, Canada to Mexico. When we analyze co-circulation of more complex variant constellations with (S: N501Y), we note that the Upper Midwest and Northeast United States contain these isolates.In summary, the viral variants that have raised concern in a few US States in recent reports are widespread. Based on the increase in the proportion of variant viruses being sampled and some empirical evidence in the United Kingdom, South Africa, and Ohio, these variants are likely to lead to increased transmission of SARS-CoV-2 across North America in the coming months.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe acknowledge support from UNC Charlotte (College of Computing and Informatics, Department of Bioinformatics and Genomics, Bioinformatics Research Center, Research and Economic Development, Government Relations, University Research Computing, and the School of Data Science).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll code, current data, and acknowledgments are available on GitHub at https://github.com/janieslab/SARS-CoV-2_VariantDashboard. To view the interactive dashboard of current variants, visit https://janieslab.github.io/sars-cov-2. https://github.com/janieslab/SARS-CoV-2_VariantDashboard https://janieslab.github.io/sars-cov-2 ER -